Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines - PubMed (original) (raw)
Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines
Ying Han et al. World J Gastroenterol. 2002 Jun.
Abstract
Aim: To investigate the expression and function of classical protein kinase C (PKC) isoenzymes in inducing MDR phenotype in gastric cancer cells.
Methods: Two cell lines were used in the study: gastric cancer cell SGC7901 and its drug-resistant cell SGC7901/VCR stepwise-selected by vincristine 0.3, 0.7 and 1.0 mg.L(-1), respectively. The expression of classical PKC (cPKC) isoenzymes in SGC7901 cells and SGC7901/VCR cells were detected using immunofluorescent cytochemistry, laser confocal scanning microscope and Western blot. The effects of anti-PKC isoenzymes antibody on adriamycin accumulation in SGC7901/VCR cells were determined using flow cytometric analysis.
Results: (1)SGC7901 cells exhibited positive staining of PKC-alpha. SGC7901/VCR cells exhibited stronger staining of PKC-alpha than SGC7901 cells. The higher dosage vincristine selected, the much stronger staining of PKC-alpha was observed on SGC7901/VCR cells. (2)Both SGC7901 and SGC7901/VCR cells exhibited positive staining of PKC-beta I and PKC-beta II with no significant difference. (3) Compared with SGC7901, SGC7901/VCR cells had decreased adriamycin accumulation and retention. Accumulation of adriamycin in SGC7901 was 5.21+/-2.56 mg.L(-1),in SGC7901/VCR 0.3 was 0.85+/-0.29 mg.L(-1), in SGC7901/VCR 0.7 was 0.81+/-0.32 mg.L(-1), and in SGC7901/VCR 1.0 was 0.80+/-0.33 mg.L(-1); Retention of adriamycin in SGC 7901 was 2.51+/-1.23 mg.L(-1), in SGC7901/VCR 0.3 was 0.47+/-0.14 mg.L(-1), in SGC7901/VCR 0.7 was 0.44+/-0.15 mg.L(-1), and in SGC 7901/VCR 1.0 was 0.41+/-0.11 mg.L(-1). (4) Fluorescence intensity presented adriamycin accumulation in SGC7901/VCR cells was increased from 1.14+/-0.36 to 2.71+/-0.94 when cells were co-incubated with anti-PKC-alpha but not with anti-PKC-beta I PKC-beta II and PKCgamma antibodies.
Conclusion: PKC-alpha, but not PKC-beta I, PKC-beta II or PKCgamma, may play a role in multidrug resistance of gastric cancer cells SGC7901/VCR.
Figures
Figure 1
Western blot (detected with anti-PKC-α antibody)
Similar articles
- [Expression and function of protein kinase C-alpha and beta I isoenzymes in drug-resistant gastric cancer cells].
Han Y, Shi Y, Li L. Han Y, et al. Zhonghua Zhong Liu Za Zhi. 2001 Mar;23(2):103-6. Zhonghua Zhong Liu Za Zhi. 2001. PMID: 11783010 Chinese. - MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells.
Shi Y, Han Y, Wang X, Zhao Y, Ning X, Xiao B, Fan D. Shi Y, et al. Gastric Cancer. 2002;5(3):154-9. doi: 10.1007/s101200200027. Gastric Cancer. 2002. PMID: 12378342 - Reversal of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR by LY980503.
Wu DL, Xu Y, Yin LX, Lu HZ. Wu DL, et al. World J Gastroenterol. 2007 Apr 21;13(15):2234-7. doi: 10.3748/wjg.v13.i15.2234. World J Gastroenterol. 2007. PMID: 17465508 Free PMC article. - [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
Wang P, Ding J, Lin T, Han S, Cao SS, Ge FL, An GQ, Li R, Lei T, Bai FH, Fan DM. Wang P, et al. Zhonghua Zhong Liu Za Zhi. 2007 Apr;29(4):258-61. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17760250 Chinese.
Cited by
- Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells.
Zhang YM, Zhao YQ, Pan YL, Shi YQ, Jin XH, Yi H, Fan DM. Zhang YM, et al. World J Gastroenterol. 2003 May;9(5):894-8. doi: 10.3748/wjg.v9.i5.894. World J Gastroenterol. 2003. PMID: 12717826 Free PMC article. - Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
Lee SK, Shehzad A, Jung JC, Sonn JK, Lee JT, Park JW, Lee YS. Lee SK, et al. Mol Cells. 2012 Jul;34(1):61-9. doi: 10.1007/s10059-012-0087-1. Epub 2012 May 23. Mol Cells. 2012. PMID: 22639047 Free PMC article. - Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.
Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP. Hu JK, et al. World J Gastroenterol. 2002 Dec;8(6):1023-8. doi: 10.3748/wjg.v8.i6.1023. World J Gastroenterol. 2002. PMID: 12439918 Free PMC article. - Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
Yan LH, Wang XT, Yang J, Lian C, Kong FB, Wei WY, Luo W, Xiao Q, Xie YB. Yan LH, et al. World J Gastroenterol. 2013 Jul 14;19(26):4155-65. doi: 10.3748/wjg.v19.i26.4155. World J Gastroenterol. 2013. PMID: 23864778 Free PMC article. - Effect of staurosporine on cycle of human gastric cancer cells.
Ha MW, Hou KZ, Liu YP, Yuan Y. Ha MW, et al. World J Gastroenterol. 2004 Jan 15;10(2):161-6. doi: 10.3748/wjg.v10.i2.161. World J Gastroenterol. 2004. PMID: 14716814 Free PMC article.
References
- Yao XQ, Qing SH. Detection of multidrug resistance gene in progvessive colon cancer and its significance. Shijie Huaren Xiaohua Zazhi. 1999;7:535–536.
- Tu SP, Jiang SH, Qiao MM, Cheng SD, Wang LF, Wu YL, Yuan YZ, Wu YX. Effect of trichosanthin on cytotoxicity and induction of apoptosis of multiple drugs resi stence cells in gastric cancer. Shijie Huaren Xiaohua Zazhi. 2000;8:150–152.
- Cheng SD, Wu YL, Zhang YP, Qiao MM, Guo QS. Abnormal drug accumulation in multidrug resistant gastric carcinoma cells. Shijie Huaren Xiaohua Zazhi. 2001;9:131–134.
- Zhan M, Yu D, Lang A, Li L, Pollock RE. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression. Cancer. 2001;92:1556–1566. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical